AcquisitionOther
Mirum Pharmaceuticals, Inc. acquired Bluejay Therapeutics
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
Mirum Pharmaceuticals, Inc. -> Bluejay Therapeutics · approximately $268.5 million (in financing)
Expand global leadership in rare disease with acquisition of brelovitug for chronic hepatitis delta virus.
Open source record (SEC) ↗